Smart Money Alert

Anthem Biosciences Limited

DecreasedInsider

ANTHEMBiotechnologyMarket Cap₹46K Cr

Deal value

₹82.67 Cr

Stake

0.18% → 0.02%

9.00 L

Trade date

18 Sept 2026

Since alert−7.8%₹891.70 → ₹822.15

Nifty 50−0.8%

Viridity Tone LLP

Insider

The move

Viridity Tone LLP sold 9 lakh shares of Anthem Biosciences for ₹82.67 Cr at ₹918.60 apiece in a market sale, trimming its stake from 0.18% to 0.02%.

About Anthem Biosciences Limited

Visit stock

A biotechnology company providing contract research, development, and manufacturing services alongside specialty ingredients production. Established in 2006, the company serves pharmaceutical and nutraceutical sectors through its integrated CRDMO capabilities and custom synthesis expertise. Its distinctive position lies in combining comprehensive development expertise with in-house manufacturing facilities, enabling end-to-end solutions for clients requiring specialized ingredient formulation, process optimization, and commercial-scale production services.

Get the next move the moment it happens.

Follow the investors and Anthem Biosciences Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Anthem Biosciences Limited shareholders All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Anthem Biosciences Limited

Quant Mutual FundExited

Quant Mutual Fund is no longer listed among the major shareholders of Anthem Biosciences Limited, meaning the previous 1.47 percent stake was either entirely sold off or reduced below the 1 percent regulatory disclosure threshold.

13 Oct 2026

SBI Mutual FundDecreased

SBI Mutual Fund trimmed its stake in Anthem Biosciences from 1.76% to 1.75%, selling 50,910 shares.